MedTrace Logo

Investigation of the Effectiveness of Myofascial Release Technique in Young Basketball Players

NCT05675514 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-25

No results posted yet for this study

Summary

In this study, it is aimed to remove the limitations that cause asymmetry and weak connections in functional movement patterns with myofascial relaxation method to be applied to certain muscles and to remove the obstacles in front of the power factor as a result of its application, to reach the highest efficiency of the athlete's performance and to reduce the risk of injury in the musculoskeletal system.Study; It was planned as a control group (n:30) and an intervention group (n:30). Apart from routine training, the intervention group will be treated twice a week for 6 weeks before the training. On the other hand, no application will be made to the control group other than routine training. The evaluations are; It will be done at the beginning of the study and after the 6-week period.

Conditions

  • Sports Physical Therapy
  • Myofascial Release Technique
  • Performance Enhancement
  • Basketball Players

Interventions

OTHER

Myofascial Release Therapy

The increasing number of basketball players also increases the risk of sports-related injuries. Basketball has the highest injury risk of all sports because the game is so powerful and fast moving. Myofascial release therapy; ıt is a form of manual therapy applied on the muscle fascia complex to restore optimal length, reduce pain and improve functions. It is known to be effective in providing rapid relief of pain and tissue sensitivity. By restoring the length and health of the restricted connective tissue with the myofascial release therapy, it aims to relieve pressure on pain sensitive structures such as nerves and blood vessels, as well as improves sports performance.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Gönül Acar, Asst. Prof · Marmara University Institute of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
16 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2023-07-15
Completion
2024-02-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675514 on ClinicalTrials.gov